These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483 [TBL] [Abstract][Full Text] [Related]
4. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Rump JA; Schölmerich J; Gross V; Roth M; Helfesrieder R; Rautmann A; Lüdemann J; Gross WL; Peter HH Immunobiology; 1990 Nov; 181(4-5):406-13. PubMed ID: 2099908 [TBL] [Abstract][Full Text] [Related]
5. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease? Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718 [TBL] [Abstract][Full Text] [Related]
6. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role. Hertervig E; Wieslander J; Johansson C; Wiik A; Nilsson A Scand J Gastroenterol; 1995 Jul; 30(7):693-8. PubMed ID: 7481534 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. Kim BG; Kim YS; Kim JS; Jung HC; Song IS Dis Colon Rectum; 2002 Aug; 45(8):1062-9. PubMed ID: 12195191 [TBL] [Abstract][Full Text] [Related]
8. [Antineutrophil cytoplasmic antibodies (ANCA) in inflammatory diseases of the digestive tract]. Lamproye A; Belaiche J; Louis E; Salmon J; Mahieu P Acta Gastroenterol Belg; 1994; 57(2):171-6. PubMed ID: 8053303 [TBL] [Abstract][Full Text] [Related]
9. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Seibold F; Slametschka D; Gregor M; Weber P Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629 [TBL] [Abstract][Full Text] [Related]
16. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Cambridge G; Rampton DS; Stevens TR; McCarthy DA; Kamm M; Leaker B Gut; 1992 May; 33(5):668-74. PubMed ID: 1612485 [TBL] [Abstract][Full Text] [Related]
17. [antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease]. Papo M; Quer JC; Pastor RM; García-Pardo G; Olona M; Prats E; Mirapeix E; Rodríguez R; Richart C Med Clin (Barc); 1998 Jan; 110(1):11-5. PubMed ID: 9527980 [TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role. Kull K; Salupere R; Uibo R; Ots M; Salupere V Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879 [TBL] [Abstract][Full Text] [Related]